image
Reach Us +44 1752 712024
SOCIETIES:
mental health, psychiatry and mental health, journals on mental health, mental health journals, journals mental health
journals for mental health, best journals for mental health, mental health journals uk, journals on psychiatry
JOURNAL COVER:
journals of psychiatry, psychiatry journals, asean, journal
Google Scholar citation report
Citations : 4829

ASEAN Journal of Psychiatry received 4829 citations as per google scholar report

ASEAN Journal of Psychiatry peer review process verified at publons
IMPACT FACTOR:
Journal Name ASEAN Journal of Psychiatry (MyCite Report)  
Total Publications 456
Total Citations 4829
Total Non-self Citations 12
Yearly Impact Factor 0.93
5-Year Impact Factor 1.44
Immediacy Index 0.1
Cited Half-life 2.7
H-index 29
Quartile
Social Sciences Medical & Health Sciences
Q3 Q2
KEYWORDS:
  • Anxiety Disorders
  • Behavioural Science
  • Biological Psychiatry
  • Child and Adolescent Psychiatry
  • Community Psychiatry
  • Dementia
  • Community Psychiatry
  • Suicidal Behavior
  • Social Psychiatry
  • Psychiatry
  • Psychiatry Diseases
  • Psycho Trauma
  • Posttraumatic Stress
  • Psychiatric Symptoms
  • Psychiatric Treatment
  • Neurocognative Disorders (NCDs)
  • Depression
  • Mental Illness
  • Neurological disorder
  • Neurology
  • Alzheimer's disease
  • Parkinson's disease

Abstract

ELECTROENCEPHALOGRAPHIC ABNORMALITY AND CLINICAL RESPONSE IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA TREATED WITH CLOZAPINE

Author(s): Amresh Shrivastava, Avinash de Sousa, Megan Johnston, Nilesh Shah, Larry Stitt

Objective: Clozapine is seen as a gold standard for treatment-refractory schizophrenia; however, it is not recommended for the treatment of first-episode psychosis mainly due to concerns of severe side effects. An indicator for response holds tremendous clinical value to select patients who can benefit from clozapine, safely. EEG abnormality has been reported to be one such parameter, yet the definite conclusion of the nature of EEG changes and its predictive value remains undetermined. The present study was undertaken to examine electroencephalographic (EEG) abnormalities and clinical response subsequent to clozapine therapy in schizophrenia. Methods: A total of 80 first-episode patients were recruited for a 12-week study, from a tertiary care center in Mumbai, India. The first episode was defined as an illness of fewer than 2 years duration and the first hospitalization since the illness. EEG abnormalities, psychopathology, and positive and negative symptoms were examined at baseline and again after 12 weeks of clozapine treatment. Results: There were some types of EEG abnormalities found in the pretreatment state in at least two-thirds of patients. The number of patients showing EEG abnormality at the end of the 12 weeks of treatment increased significantly, which included theta (θ) frequency, slow waves, and sharp waves. Symptomatically, significant improvement was seen in both positive as well as negative symptoms scores. However, there was no significant correlation between EEG changes and clinical outcomes. Conclusion: There was a significant abnormality in the number of patients exhibiting EEG abnormalities. Baseline pretreatment EEG abnormalities were present in a considerable number of patients, and these EEG abnormalities did not significantly correlate with clinical improvement, except suggesting a trend towards such correlation.


PDF

scan code
INDEXATION OF THE JOURNAL
Get the App